Search details
1.
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia.
Blood
; 140(23): 2451-2462, 2022 12 08.
Article
in English
| MEDLINE | ID: mdl-35917442
2.
Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity.
Blood
; 135(6): 399-410, 2020 02 06.
Article
in English
| MEDLINE | ID: mdl-31856277
3.
Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia.
Mol Ther
; 29(12): 3410-3421, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34174441
4.
Suppression of leukemia development caused by PTEN loss.
Proc Natl Acad Sci U S A
; 108(4): 1409-14, 2011 Jan 25.
Article
in English
| MEDLINE | ID: mdl-21212363
5.
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.
J Immunother Cancer
; 11(12)2023 12 06.
Article
in English
| MEDLINE | ID: mdl-38056893
6.
Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells.
bioRxiv
; 2023 Oct 09.
Article
in English
| MEDLINE | ID: mdl-37873468
7.
A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors.
Med
; 4(7): 457-477.e8, 2023 Jul 14.
Article
in English
| MEDLINE | ID: mdl-37172578
8.
Generation of T-cell-receptor-negative CD8αß-positive CAR T cells from T-cell-derived induced pluripotent stem cells.
Nat Biomed Eng
; 6(11): 1284-1297, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35941192
9.
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma.
Nat Commun
; 13(1): 7341, 2022 11 29.
Article
in English
| MEDLINE | ID: mdl-36446823
10.
Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia.
J Immunother Cancer
; 10(11)2022 11.
Article
in English
| MEDLINE | ID: mdl-36319065
11.
Hydrophobic surfaces for enhanced differentiation of embryonic stem cell-derived embryoid bodies.
Proc Natl Acad Sci U S A
; 105(38): 14459-64, 2008 Sep 23.
Article
in English
| MEDLINE | ID: mdl-18791068
12.
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy.
Cell Stem Cell
; 28(12): 2062-2075.e5, 2021 12 02.
Article
in English
| MEDLINE | ID: mdl-34525347
13.
Continuous sorting of heterogeneous-sized embryoid bodies.
Lab Chip
; 10(13): 1678-82, 2010 Jul 07.
Article
in English
| MEDLINE | ID: mdl-20376391
14.
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy.
Sci Transl Med
; 12(568)2020 11 04.
Article
in English
| MEDLINE | ID: mdl-33148626
15.
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.
Semin Immunopathol
; 41(1): 59-68, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30361801
16.
Author Correction: Generation of T-cell-receptor-negative CD8αß-positive CAR T cells from T-cell-derived induced pluripotent stem cells.
Nat Biomed Eng
; 2024 Feb 12.
Article
in English
| MEDLINE | ID: mdl-38347164
17.
GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.
Cancer Res
; 77(20): 5664-5675, 2017 10 15.
Article
in English
| MEDLINE | ID: mdl-28790065
18.
Generation of skeletal muscle cells from pluripotent stem cells: advances and challenges.
Front Cell Dev Biol
; 3: 29, 2015.
Article
in English
| MEDLINE | ID: mdl-26029693
19.
Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells.
Stem Cell Reports
; 2(3): 366-81, 2014 Mar 11.
Article
in English
| MEDLINE | ID: mdl-24672758
20.
Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery.
Stem Cells Transl Med
; 3(2): 149-60, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24396035